« FDA Approvals - Thoratec Receives FDA Approval of Continued Access Protocol for Bridge | Main | FDA Approvals - Thoratec Receives FDA Approval of Continued Access Protocol for Bridge »

FDA Approves New Treatment for Myelodysplastic Syndromes (MDS) FDA approved


FDA Approves New Treatment for Myelodysplastic Syndromes (MDS)
FDA approved Dacogen (decitabine) injection for the treatment of myelodysplastic syndromes (MDS). Dacogen is a new molecular entity that received orphan drug status.
 

©2006 FDA-News.com. All rights reserved.